Suppr超能文献

白细胞介素 6 与白蛋白比值作为终末期肾病患者死亡率的优越预测因子。

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients.

机构信息

Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden,

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, China,

出版信息

Am J Nephrol. 2023;54(7-8):268-274. doi: 10.1159/000531191. Epub 2023 May 24.

Abstract

INTRODUCTION

In patients with chronic kidney disease (CKD), high interleukin-6 (IL-6) and low albumin circulating concentrations are associated with worse outcomes. We examined the IL-6-to-albumin ratio (IAR) as a predictor of risk of death in incident dialysis patients.

METHODS

In 428 incident dialysis patients (median age 56 years, 62% men, 31% diabetes mellitus, 38% cardiovascular disease [CVD]), plasma IL-6 and albumin were measured at baseline to calculate IAR. We compared the discrimination of IAR with other risk factors for predicting 60-month mortality using receiver operating characteristic curve (ROC) and analyzed the association of IAR with mortality using Cox regression analysis. We divided patients into IAR tertiles and analyzed: (1) cumulative incidence of mortality and the association of IAR with mortality risk in Fine-Gray analysis, taking kidney transplantation as competing risk and (2) the restricted mean survival time (RMST) to 60-month mortality and differences of RMST (∆RMST) between IAR tertiles to describe quantitative differences of survival time.

RESULTS

For all-cause mortality, the area under the ROC curve (AUC) for IAR was 0.700, which was greater than for IL-6 and albumin separately, while for CV mortality, the AUC for IAR (0.658) showed negligible improvement over IL-6 and albumin separately. In Cox regression analysis, IAR was significantly associated with all-cause mortality but not with CV mortality. Both high versus low and middle versus low tertiles of IAR associated with higher risk of all-cause mortality, subdistribution hazard ratio of 2.22 (95% CI 1.40-3.52) and 1.85 (95% CI 1.16-2.95), respectively, after adjusting for age, sex, diabetes mellitus, CVD, smoking, and estimated glomerular filtration rate. ∆RMST at 60 months showed significantly shorter survival time in middle and high IAR tertiles compared with low IAR tertile for all-cause mortality.

CONCLUSIONS

Higher IAR was independently associated with significantly higher all-cause mortality risk in incident dialysis patients. These results suggest that IAR may provide useful prognostic information in patients with CKD.

摘要

简介

在慢性肾脏病(CKD)患者中,高白细胞介素-6(IL-6)和低白蛋白循环浓度与预后不良相关。我们研究了白细胞介素-6与白蛋白比值(IAR)作为透析患者死亡风险的预测因子。

方法

在 428 例新发病例透析患者(中位年龄 56 岁,62%为男性,31%患有糖尿病,38%患有心血管疾病[CVD])中,基线时测量血浆 IL-6 和白蛋白以计算 IAR。我们使用接受者操作特征曲线(ROC)比较了 IAR 与其他预测 60 个月死亡率的危险因素的鉴别能力,并使用 Cox 回归分析分析了 IAR 与死亡率的关系。我们将患者分为 IAR 三分位数,并分析:(1)死亡率的累积发生率以及 Fine-Gray 分析中 IAR 与死亡率风险的关系,以肾脏移植为竞争风险,(2)到 60 个月死亡率的限制性平均生存时间(RMST)和 IAR 三分位数之间的 RMST 差异(∆RMST),以描述生存时间的定量差异。

结果

对于全因死亡率,IAR 的 ROC 曲线下面积(AUC)为 0.700,大于单独的 IL-6 和白蛋白,而对于心血管死亡率,IAR 的 AUC(0.658)与单独的 IL-6 和白蛋白相比,仅略有改善。在 Cox 回归分析中,IAR 与全因死亡率显著相关,但与心血管死亡率无关。与低 IAR 三分位数相比,高 IAR 三分位数和中 IAR 三分位数与全因死亡率的风险更高相关,亚分布危险比分别为 2.22(95%CI 1.40-3.52)和 1.85(95%CI 1.16-2.95),调整年龄、性别、糖尿病、CVD、吸烟和估计肾小球滤过率后。60 个月时的∆RMST 显示,与低 IAR 三分位数相比,中 IAR 三分位数和高 IAR 三分位数的全因死亡率的生存时间明显更短。

结论

较高的 IAR 与新发病例透析患者的全因死亡率风险显著增加独立相关。这些结果表明,IAR 可能为 CKD 患者提供有用的预后信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df75/10623391/de6b8e4af596/ajn-2023-0054-07-8-531191_F01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验